ESH MM 2018 | Early detection and intervention in myeloma: a critical point

While our treatments for multiple myeloma (MM) are improving all the time, the best time to eradicate disease is early on. Here, Jesús San Miguel, MD, PhD, of the University of Navarra, Pamplona, Spain, discusses the importance of early intervention from the European School of Haematology (ESH) International Conference on MM 2018, held in Mandelieu, France.